Suchergebnisse - "Lau, Kristy T K"

PubPharm (19)

1

Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection

enthalten in: International journal of antimicrobial agents | 2024

von Wong, C. | Lau, K. | Au, I. | +2

2

Comparison of Bivalent and Monovalent mRNA Vaccine Boosters

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Wong, C. | Lau, K. | Au, I. | +2

3

Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection : a target trial emulation

enthalten in: Nature medicine | 2024

von Wong, C. | Lau, K. | Chung, M. | +6

4

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis : target trial emulation

enthalten in: Nature communications | 2023

von Wong, C. | Lau, J. | Au, I. | +5

5

Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong : a population-wide retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2023

von Wong, C. | Lau, K. | Au, I. | +5

CommentIn: Lancet Infect Dis. 2023 Jun;23(6):637-639. - PMID 36796396

6

Real-world effectiveness of nirmatrelvir-ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants

enthalten in: The Lancet. Infectious diseases | 2023

von Wong, C. | Lau, K. | Leung, G.

CommentOn: Lancet Infect Dis. 2023 Jun;23(6):696-705. - PMID 36780912

7

Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong

enthalten in: JAMA network open | 2023

von Lui, D. | Chung, M. | Lau, E. | +6

8

Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave : a retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2022

von Wong, C. | Au, I. | Lau, K. | +3

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1650-1651. - PMID 36029797

9

Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong : an observational study

enthalten in: Lancet (London, England) | 2022

von Wong, C. | Au, I. | Lau, K. | +3

CommentIn: Lancet. 2022 Oct 8;400(10359):1175-1176. - PMID 36215994

10

Optimal Timing of Remdesivir Initiation in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Administered With Dexamethasone

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Wong, C. | Lau, K. | Au, I. | +4